ASHOK LEYLAND FY16
AL’s annual report for FY16 highlights stellar standalone operating
performance. While revenue grew 39% to INR188.2b, EBITDA
doubled to INR21.7b, driven primarily by domestic business.
Subsidiaries excluding Hinduja Leyland Finance (HLF) played
spoilsport and continued to incur losses. The standalone entity
infused INR1.8b of fresh investments while writing-off investments
of INR5.8b (INR1.7b goodwill on consolidated basis) towards these
subsidiaries. Goodwill-on-consolidation of INR6.4b (13% of NW)
remained outstanding as at the end of FY16. Standalone operating
cash flows declined on high cash tax payment and increased
working capital requirements.
The
ART
of annual report analysis
INR1.8b infused in ailing subsidiaries
Receivables outstanding > 6 months
remain high at INR2.7b.
ICDs of INR5b given and squared off
during the year to unknown recipients.
A
NNUAL
R
EPORT
T
HREADBARE
28 July 2016
Standalone business performance impressive:
Net revenue
grew 39% to INR188.2b (FY15: INR135.6b), led by domestic
business. Market share in MHCVs grew from 27.2% to 31.3%.
Gross margin expansion of 300bp drove up EBITDA margin to
11.5% (FY15: 7.6%).
Subsidiaries (ex HLF) and JVs continued to drag earnings;
required cash infusion:
Hinduja Leyland Finance’s PAT grew 34%
to INR1.5b. However, other subsidiaries/JVs continued to make
losses. Albonair Gmbh, which incurred a loss of INR0.2b in FY16,
has been reclassified from held-for-sale to non-current (and has
been consolidated) from March31, 2016; which could impact
FY17 earnings. The standalone entity infused INR1.8b to these
entities in FY16 to support their operations while writing-off
INR5.8b of investments.
Capitalization of exchange losses supported earnings:
Following the amended AS11, AL capitalized exchange losses of
INR1b (6.0% of PBT) to the balance sheet. Ind-AS will require
MTM losses on new loans availed post April 1, 2016 (if any) to
be charged through the income statement.
Higher tax outgo impacted operating cash flows:
Standalone
operating cash flows declined to INR16.8b (FY15: INR17.8b) on
account of high tax payments and INR1.2b increase in working
capital. Receivables exceeding six months increased to INR2.7b
(22% of total receivables) v/s INR2.4b as at the end of FY15.
ICDs of INR5b given and squared off during the year:
Cash flows
highlight inter-corporate deposits (ICDs) extended of INR5.0b,
which were squared-off during the year. The beneficiary of this
is not available. However, the management has highlighted that
the maximum outstanding pertaining to this during the year
stood at INR2b.
Stock Info
Bloomberg
CMP (INR)
Equity Shares (m)
52-Week Range (INR)
M.Cap. (INR b)/(USD b)
1,6,12 Rel. Perf. (%)
AL IN
290
475.1
341/201
137.9/2.1
-9/-14/22
Y/E Mar
Sale Sales
EBITDA
Adj. PAT
EPS (INR)
EPS Gr. (%)
BV/Sh (INR)
Payout (%)
P/E (x)
P/BV (x)
E: MOSL Estimates
Standalone financial summary (INR b)
2016
112.4
7.5
4.3
9.1
24.2
40.8
33.7
32.0
7.1
2017E
129.9
9.7
5.8
12.3
34.8
49.7
27.0
23.8
5.9
2018E
147.0
12.2
7.6
16.1
31.2
62.2
22.4
18.1
4.7
Auditor’s name
MS Krishnaswami & Rajan and Deloitte Haskins & Sells LLP
ART will present a threadbare portrait of annual reports - statistical, strategic and structured. We believe ART's wide canvas - from accounting and auditing issues to
operating performance to management insights to governance matters - will help readers paint a clearer picture of the stock's investment worthiness.
Sandeep Ashok Gupta
(S.Gupta@MotilalOswal.com); +91 22 39825544
Mehul Parikh
(Mehul.Parikh@MotilalOswal.com); +9122 3010 2492 /
Somil Shah
(Somil.Shah@MotilalOswal.com); +91 22 3312 4975
Investors are advised to refer through important disclosures made at the last page of the Research Report.
Motilal Oswal research is available on www.motilaloswal.com/Institutional-Equities, Bloomberg, Thomson Reuters, Factset and S&P Capital.